202 related articles for article (PubMed ID: 21659416)
1. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
Vandenbroucke RE; Dejonckheere E; Libert C
Eur Respir J; 2011 Nov; 38(5):1200-14. PubMed ID: 21659416
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD).
Daheshia M
Curr Med Res Opin; 2005 Apr; 21(4):587-94. PubMed ID: 15899108
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases in asthma and COPD.
Demedts IK; Brusselle GG; Bracke KR; Vermaelen KY; Pauwels RA
Curr Opin Pharmacol; 2005 Jun; 5(3):257-63. PubMed ID: 15907912
[TBL] [Abstract][Full Text] [Related]
6. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 in lung remodeling.
Atkinson JJ; Senior RM
Am J Respir Cell Mol Biol; 2003 Jan; 28(1):12-24. PubMed ID: 12495928
[TBL] [Abstract][Full Text] [Related]
8. Respirology year-in-review 2008: basic science.
Kolb MR; Yang I
Respirology; 2009 Apr; 14(3):318-26. PubMed ID: 19353767
[No Abstract] [Full Text] [Related]
9. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.
Lagente V; Le Quement C; Boichot E
Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications.
Oikonomidi S; Kostikas K; Tsilioni I; Tanou K; Gourgoulianis KI; Kiropoulos TS
Curr Med Chem; 2009; 16(10):1214-28. PubMed ID: 19355880
[TBL] [Abstract][Full Text] [Related]
11. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
Belvisi MG; Bottomley KM
Inflamm Res; 2003 Mar; 52(3):95-100. PubMed ID: 12755372
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases involvement in pathologic conditions.
Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
[TBL] [Abstract][Full Text] [Related]
13. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.
Abd-Elaziz K; Jesenak M; Vasakova M; Diamant Z
Curr Opin Pulm Med; 2021 Jan; 27(1):54-60. PubMed ID: 33065600
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).
Wu Y; Li J; Wu J; Morgan P; Xu X; Rancati F; Vallese S; Raveglia L; Hotchandani R; Fuller N; Bard J; Cunningham K; Fish S; Krykbaev R; Tam S; Goldman SJ; Williams C; Mansour TS; Saiah E; Sypek J; Li W
Bioorg Med Chem Lett; 2012 Jan; 22(1):138-43. PubMed ID: 22153340
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
Hu J; Van den Steen PE; Sang QX; Opdenakker G
Nat Rev Drug Discov; 2007 Jun; 6(6):480-98. PubMed ID: 17541420
[TBL] [Abstract][Full Text] [Related]
16. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
Tambunting F; Beharry KD; Hartleroad J; Waltzman J; Stavitsky Y; Modanlou HD
Pediatr Pulmonol; 2005 Jan; 39(1):5-14. PubMed ID: 15521085
[TBL] [Abstract][Full Text] [Related]
17. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in lung diseases.
Ohbayashi H
Curr Protein Pept Sci; 2002 Aug; 3(4):409-21. PubMed ID: 12370004
[TBL] [Abstract][Full Text] [Related]
19. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury.
Albaiceta GM; Gutierrez-Fernández A; García-Prieto E; Puente XS; Parra D; Astudillo A; Campestre C; Cabrera S; Gonzalez-Lopez A; Fueyo A; Taboada F; López-Otin C
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):555-63. PubMed ID: 19995943
[TBL] [Abstract][Full Text] [Related]
20. Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD.
Churg A; Zhou S; Wright JL
Eur Respir J; 2012 Jan; 39(1):197-209. PubMed ID: 21920892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
